Submissions

Online Submissions

Already have a Username/Password for The Indonesian Biomedical Journal?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

1.    GENERAL TERMS

The Indonesian Biomedical Journal (InaBJ) welcomes articles covering all aspects of biomedical sciences. All submitted manuscripts must not previously published and not under consideration for publication elsewhere. Manuscripts may come from any country but must be written in English. Manuscript may be submitted as review and research articles. There are submission and publication fees for this journal.

All manuscripts are subjected to peer review. All submissions must be accompanied by abstracts of the authors' manuscripts on related subjects that are in press or under editorial review. Electronic reprints of related published manuscripts by the author/s or manuscripts in press also may be helpful to the reviewers.

Upon acceptance, author/s must transfer copyright to the Prodia Education and Research Institute (PERI). Accepted manuscripts become permanent property of PERI and may not be reproduced by any means, in whole or in part, without the written consent from PERI. It is the author/s' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publication.

 

2. PREPARATION OF THE MANUSCRIPT

a. Manuscript should be submitted in Word File (.doc).
b. Formatted as standard A4 page setup.
c. The text should be double-spaced with 1-inch margin on the left and right sides.
d. Use 12-point Times New Roman font.
e. Manuscript should be arranged in the following order:
    - Title Page, including title, author (first, middle, last name), author's affiliation, corresponding author's contact information, running title (≤ 8 words),
      keywords (≤ 8 keywords), and any disclaimers
    - Abstract
    - Manuscript body, including Introduction, Methods, Results, Discussion, Conclusion and References
    - Acknowledgment, Source of Funding Statement, Conflict of Interest and Author's Contribution
    - Figures and Tables.
f. Number all pages at bottom right.
g. Decimal fraction is written in English version (for thousand use point (,) and decimal use comma (.)).
h. Tables are drawn without vertical lines.
i. Figures should be submitted in jpg, tif, png or gif file format.

 

3.    REQUIREMENTS OF EACH MANUSCRIPT TYPE

  • Review Article: Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than eight figures and/or tables in total and no more than 250 references.
  • Research Article: Research Articles should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 40 references.


4. ABSTRACT

Provide an abstract of no more than 300 words (for Review Articles) or 250 words (for Research Articles). Structured-abstract should be followed in writing any type of Articles.


5. REFERENCES

  • References should be according to the Vancouver system.
  • List all authors when there are six or fewer; when there are seven or more, list the first six, followed by "et al.".
  • Sequential number of references in main text. Please follow in detail all examples below:

Article:
Kumaladewi P, Harahap WA, Nova B, Widodo I, Karsono R, Sandra F, et al. Role of estrogen receptor alpha rs3798577 polymorphism in breast carcinoma risk determination. Indones Biomed J. 2022; 14(4): 436-41.

Book:
Cooper GM, Adams KW. The Cell : A Molecular Approach. 9th ed. New York: Oxford University Press; 2023.

Chapter in a book:
Li S, Lee KH, Zhang W. Multiepitope fusion antigen: MEFA, an epitope- and structure-based vaccinology platform for multivalent vaccine development. In: Bidmos F, Bossé J, Langford P, editors. Bacterial Vaccines. Methods in Molecular Biology. New York: Humana; 2022. p.151–169.

Dissertation/ Thesis/ Essay:
Arlauckas SP. Near infrared fluorescent choline kinase alpha inhibitors for cancer imaging and therapy [Dissertation]. Philadelphia: University of Pennsylvania; 2015.

Part of Website/Monograph:
Medline Plus [Internet]. Bethesda: US National Library of Medicine; ©2009. Complementary and Integrative Medicine [update 2020 May 21; cited 2023 Feb 1]. Available from: https://medlineplus.gov/complementaryandintegrativemedicine.html.

Conference Paper:
Oktaviono YH, Sandra F, Hutomo SA, Pramudita C, Isaridha IA, Susanti M, et al. In: Jarm T, Cvetkoska A, Mahnič-Kalamiza S, Miklavcic D, editors. 8th European Medical and Biological Engineering Conference. Proceedings of the EMBEC 2020, November 29 – December 3, 2020. Portorož, Slovenia: Springer; 2020. p.622–30.

 

6. UNIT OF MEASUREMENT

  • Authors can express all measurements in Conventional or International System (SI) units.
  • Drug names must use generic names. When proprietary brands are used in research, include the brand name, the name and location (city & country) of the manufacturer in parentheses after the first mention of the generic name.
 

7. MANUSCRIPT TEMPLATE

You can use templates below for submitting manuscript to InaBJ.


 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration.
  2. Proof of permission was obtained to reproduce illustrations, tables, etc. from other publication.
  3. The submission has been written and structured according to the Author Guidelines.
  4. Author/s has/have to certify that: I have been granted authorization by my co-author/s to enter into these arrangements.
  5. I hereby declare, on behalf of myself and my co-author/s, that:
    • The manuscript submitted is an original work and has neither been published in any other peer-reviewed journal nor is under consideration for publication by any other journal. More so, the work has been carried out in the author/s’ lab and the manuscript does not contravene any existing copyright or any other third party rights.
    • I am/we are the sole author/s of the manuscript and maintain the authority to enter into this agreement and the granting of rights to the publisher (PERI), does not infringe any clause of this agreement.
    • The manuscript contains no such material that may be unlawful, defamatory, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the agreement.
    • I/we have taken due care that the scientific knowledge and all other statements contained in the manuscript conform to true facts and authentic formulae and will not if followed precisely, be detrimental to the user.
    • I/we permit the adaptation, preparation of derivative works, oral presentation or distribution, along with the commercial application of the work.
    • No responsibility is assumed by InaBJ and PERI, its staff, or members of the editorial boards for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by InaBJ.
 

Copyright Notice

Author/s who publish in any InaBJ print & online journal will transfer copyright to their work to PERI. 

By submitting a manuscript, the author/s agree that the copyright of their manuscript is transferred to PERI, if and when the manuscript is accepted for publication. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. However, the copyright will be released to the author/s when the manuscript is rejected.

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.